Ossur Outlook - Q3 2008
Highlights:
* Sales estimated to be 87 million USD up 6% from Q3 last
year
* Operational profit estimated to be 15 million USD up 79%
* Net profit estimated 12 million USD up 480% from Q3 last
year
* EBITDA estimated 20 million USD up 43%
At a Board of Directors meeting 10 October, it was decided to publish
immediately outlook for Q3. This is done in light of highly unusual
situation at the financial markets and in order to facilitate and
enable primary insiders to trade their shares. The Financial
Statements are in the process of being finalized. This outlook is
based on actual performance for July and August and estimates for
September. One-time other income includes USD 2 million due to
milestone payment from the advanced wound care product line which was
divested earlier this year.
For further details, see the press release in the attachment.